Pune-based Emcure Pharmaceuticals, one of India’s biggest unlisted pharma companies, filed its draft red herring prospectus (DRHP) with the market regulator Sebi on Thursday to raise money through an initial public offer.

The issue estimated to be around Rs 4,500 crore would comprise fresh shares of up to Rs 1,100 crore and an offer for sale by promoters and an existing investor of up to 18.17 million shares.
Read more at https://economictimes.indiatimes.com/markets/ipos/fpos/emcure-pharm...